<code id='48677B6EDB'></code><style id='48677B6EDB'></style>
    • <acronym id='48677B6EDB'></acronym>
      <center id='48677B6EDB'><center id='48677B6EDB'><tfoot id='48677B6EDB'></tfoot></center><abbr id='48677B6EDB'><dir id='48677B6EDB'><tfoot id='48677B6EDB'></tfoot><noframes id='48677B6EDB'>

    • <optgroup id='48677B6EDB'><strike id='48677B6EDB'><sup id='48677B6EDB'></sup></strike><code id='48677B6EDB'></code></optgroup>
        1. <b id='48677B6EDB'><label id='48677B6EDB'><select id='48677B6EDB'><dt id='48677B6EDB'><span id='48677B6EDB'></span></dt></select></label></b><u id='48677B6EDB'></u>
          <i id='48677B6EDB'><strike id='48677B6EDB'><tt id='48677B6EDB'><pre id='48677B6EDB'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:27365
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Amylyx ALS drug fails large clinical trial
          Amylyx ALS drug fails large clinical trial

          JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

          DarronCummings/APInasurprisemove,theFoodandDrugAdministrationhascalledforameetingofoutsideadvisersto